Sponsor Pipeline

Beijing Tricision Biotherapeutics Inc Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
0
Recruiting
1
Disease Areas
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-07-20 NCT07715097 Survivin-Targeted Dendritic Cell (DC) Cell Injection for Newly Diagnosed Glioblastoma Phase 2 Not Yet Recruiting
Active Trials by Phase
Phase 2
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07715097 Survivin-Targeted Dendritic Cell (DC) Cell Injection for Newly Diagnosed Glioblastoma Glioblastoma Not Yet Recruiting
Phase 1
NCT06524063 Targeted Survivin DC Cell Injection for the Treatment of GBM Glioblastoma Not Yet Recruiting
Disease Areas
Glioblastoma (2)
Get alerts when Beijing Tricision Biotherapeutics Inc's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free